Apathy as a behavioural marker of cognitive impairment in Parkinson’s disease: a longitudinal analysis
Glen P. Martin(Manchester Academic Health Science Centre), Iracema Leroi(Trinity College Dublin), David Allsop(Lancaster University), Peter J. Diggle(Lancaster University), Kathryn McDonald(Salford Royal NHS Foundation Trust)
Cited by 45
Related Papers
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.3k
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
|The Lancet Neurology|2009|460
Cognitive Impairment in Parkinson Disease
|Journal of Geriatric Psychiatry and Neurology|2012|380
Randomized placebo‐controlled trial of donepezil in cognitive impairment in Parkinson's disease
|International Journal of Geriatric Psychiatry|2004|228
Neuropsychiatry of Huntington’s Disease and Other Basal Ganglia Disorders
|Psychosomatics|2000|223